The QKI-PLP pathway controls SIRT2 abundance in CNS myelin

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Sirtuin 2 (SIRT2) is a deacetylase in oligodendrocytes (OLs), crucial for myelin production in the central nervous system (CNS).
• SIRT2 expression is elevated during active myelination and reduced in myelin-deficient conditions.
• The regulatory mechanisms of SIRT2 in OLs and myelin are not fully understood.

Purpose of the Study:

• To investigate the regulation of SIRT2 expression in oligodendrocytes.
• To determine the role of the QKI pathway and proteolipid protein (PLP) in SIRT2 regulation.
• To elucidate the impact of PLP and DM20 on SIRT2 abundance in myelin.

Main Methods:

• Analysis of SIRT2 mRNA and protein levels in homozygous quaking-viable (qk(v)/qk(v)) mutant mice with QKI deficiency.
• Assessment of SIRT2 expression following rescue with the QKI6 isoform in qk(v)/qk(v) OLs.
• Examination of SIRT2 protein in myelin tracts of PLP-ISEdel mutant mice with selective PLP reduction.

Main Results:

• SIRT2 protein was significantly reduced in qk(v)/qk(v) mice, while SIRT2 mRNA levels remained unaffected, indicating post-transcriptional regulation.
• PLP mRNA was selectively downregulated in qk(v)/qk(v) mice, and QKI6 expression restored both PLP and SIRT2 protein levels.
• SIRT2 protein was diminished in myelin tracts of PLP-ISEdel mice, correlating with reduced PLP but not DM20.

Conclusions:

• SIRT2 expression in myelin is dependent on proteolipid protein (PLP) levels.
• The QKI-dependent pathway regulates SIRT2 abundance through selective control of PLP.
• These findings highlight a novel regulatory axis impacting myelin composition and oligodendrocyte function.